TGA LICENSED MEDICINAL CANNABIS PRODUCER

Medicinal Cannabis

for australian clinical care

Curaleaf Australia supports healthcare professionals with GMP-certified formulations, clinical evidence and reliable supply for patient care.

GMP Certified

Validated manufacturing, every batch.

Scientific Background

Grounded in rigorous clinical evidence.

HCP Education

Clinical resources. Practical support.


Pioneering medical cannabis research

Our ambition is to make sure cannabis-based treatments are backed with the same rigorous science as other pharmaceuticals

Curaleaf Australia Portfolio

Our complete product range

Flowers

Medicinal cannabis flowers sourced from certified cultivation facilities in Canada and Portugal. The portfolio includes a range of cannabinoid profiles and product formats developed to meet the requirements of healthcare professionals and patients.

Browse

Pastilles

Cannabinoid pastilles manufactured in Spain under GMP standards, offering a convenient oral dosage format within the Curaleaf product portfolio. Available in selected cannabinoid strengths and flavour profiles.

Browse

Vape

Curaleaf inhalation products have been developed for use with the QMID device platform, combining formulation and device technology within a single integrated system. Manufactured in Australia, these products form part of Curaleaf's next-generation cannabinoid delivery ecosystem.

Browse

Full Spectrum Extracts

Cannabis full spectrum extracts manufactured in Spain under GMP standards and available in a range of cannabinoid ratios and concentrations. Developed to provide healthcare professionals with flexible formulation options within the Curaleaf portfolio.

Browse

CURALEAF WORLDWIDE

We are international

An expanding global network operating across three continents.

0

Employees

A multidisciplinary team spanning science, manufacturing, regulatory affairs and clinical support.

0

Countries

Operating across regulated markets in Europe, North America and Australia.

0

EU-GMP Facilities

Ensuring consistent quality and compliance across every product.

Latest news & insights

Stay up to date with the latest from Curaleaf.

Standardising inhaled cannabinoid delivery

 Standardising inhaled cannabinoid delivery 1000 1250 Curaleaf Australia

Dose variability has long been one of the central challenges in inhaled cannabinoid therapy. In…

ANZCCP 2026

 ANZCCP 2026 1080 1350 Curaleaf Australia

Curaleaf International attends ANZCCP 2026 in Noosa Curaleaf International was proud to participate in ANZCCP…

AMCA UIC Conference

 AMCA UIC Conference 1920 1920 Curaleaf Australia

Curaleaf International at the AMCA UIC Conference 2026 Curaleaf International was pleased to attend the…

Don't miss any update

©2026 CURALEAF AUSTRALIA

Privacy Policy

LEVEL 5, 126 PHILLIP STREET, SYDNEY, 2000, NSW

curaleaf.aus@curaleafint.com

For healthcare professionals only. Curaleaf Australia products are prescription-only and intended for healthcare professionals and stakeholders only. This website does not promote the use or supply of medicinal cannabis to the public. Not for public promotion or recreational use.

Back to top